Home » Newsletters » BioWorld Science

BioWorld Science

March 21, 2003

View Archived Issues

Advances at Celltech summarized in preliminary announcement of 2002 results

New COX-2 inhibitors and their use patented by Pharmacia

Novel agents with AGE-breaking, AGE-inhibitory and free radical-scavenging activity

Shionogi BioResearch claims compounds with Taxol-enhancing activity

MitoKor synthesizes and tests new antiarthritic agents

Novel platelet ADP receptor inhibitors in Millennium development pipeline

Mochida researchers present novel tryptase inhibitors

Newly discovered thrombin inhibitors patented by Merck

Immunosuppressants from AstraZeneca with utility in obstructive airways diseases

Novel selective alpha4 integrin inhibitors covered by Celltech patent

Promising anticonvulsant activity of agmatine in rat seizure model

Selective NCX inhibitor reduces myocardial ischemic injury in rabbits

Zelandopam prevents cisplatin-induced renal failure in rats

Altana reports key product progress

Paxceed produces positive response in psoriasis patients

Preliminary phase II results, IND submitted for exenatide LAR in type 2 diabetes

Lantus approved in E.U. for pediatric use

OncoMab and Medarex join forces for cancer antibody development

Genzyme begins enrollment for Myozyme trial in Pompe's disease

Aderis receives DTI-0009 development milestone payment

New data on the safety profile of tadalafil in erectile dysfunction

WHO coordinates research on mysterious pneumonia-like disease

Promising preclinical findings for aplidine in leukemia and lymphoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...